JNeurooncol Profile Banner
Journal of Neuro-Oncology Profile
Journal of Neuro-Oncology

@JNeurooncol

Followers
9K
Following
328
Media
2K
Statuses
2K

The official twitter account for the Journal of Neuro-Oncology (JNO), the official journal of the AANS/CNS Section on Tumors

Charlottesville, VA
Joined January 2018
Don't wanna be here? Send us removal request.
@JNeurooncol
Journal of Neuro-Oncology
13 hours
Please read our newest November 2025 edition! #JNO https://t.co/XifbaPABk1
0
1
4
@JNeurooncol
Journal of Neuro-Oncology
3 days
Gonzalez-Aponte et al. explore the daily fluctuations in glioblastoma gene expression and protein levels, hypothesizing that these predictable rhythms can be used to maximize DNA damage and therapeutic efficacy. #JNO Read more here: https://t.co/2eDZ6vL8fo
0
1
6
@JNeurooncol
Journal of Neuro-Oncology
4 days
Tariq et al. introduce the "Brain State Theory" as a framework for guiding surgical planning and minimizing cognitive and functional deficits from glioma surgery. #JNO #brainmapping Read more here: https://t.co/9Jlz6AS0Q0
1
25
109
@JNeurooncol
Journal of Neuro-Oncology
5 days
Looking forward to this upcoming TumorTalk hosted by #SSF and sponsored by @GammaTile. See you on Monday ! Article: https://t.co/NrupVic2ov Register here for free: https://t.co/VwX9akREOw
0
0
1
@JNeurooncol
Journal of Neuro-Oncology
6 days
Looking forward to this upcoming TumorTalk hosted by #SSF and sponsored by @GammaTile. See you on Monday ! Article: https://t.co/NrupVic2ov Register here for free: https://t.co/VwX9akREOw
0
1
8
@JNeurooncol
Journal of Neuro-Oncology
7 days
Looking forward to this upcoming TumorTalk hosted by #SSF and sponsored by @GammaTile. See you on Monday ! Article: https://t.co/NrupVic2ov Register here for free: https://t.co/VwX9akREOw
1
3
8
@JNeurooncol
Journal of Neuro-Oncology
8 days
Looking forward to this upcoming TumorTalk hosted by #SSF and sponsored by @GammaTile. See you on Monday ! Article: https://t.co/NrupVic2ov Register here for free: https://t.co/VwX9akREOw
0
0
3
@JNeurooncol
Journal of Neuro-Oncology
17 days
Roh et al. studied lung adenocarcinoma brain metastases treated with GKRS. Second- and third-generation EGFR TKIs improved local control, while exon 19 deletion conferred better distant brain control compared with exon 21 L858R. #JNO Read more: https://t.co/cwVpGeINrs
0
2
7
@JNeurooncol
Journal of Neuro-Oncology
18 days
Ogunsola et al. tracked frailty in 465 metastatic spine disease patients. Frailty worsened rapidly after spine metastasis diagnosis, driven by anemia, malnutrition, and electrolyte abnormalities, and strongly predicted 2-year survival. #JNO Read more: https://t.co/A5TABM4MRS
0
1
2
@JNeurooncol
Journal of Neuro-Oncology
20 days
Oi et al. used MRI-based radiomics to explore predictors of growth in incidentally discovered meningiomas. Ten quantitative features across first order, shape, and texture matrices differentiated growing from stable tumors. #JNO Read more:
Tweet card summary image
link.springer.com
Journal of Neuro-Oncology - Predicting future tumor growth from initial imaging of incidentally discovered meningioma (IDM) could inform treatment decisions. However, most factors identified in...
0
4
8
@JNeurooncol
Journal of Neuro-Oncology
22 days
Deboeuf et al. examined spinal meningiomas in NF2-related schwannomatosis. These tumors associated with intracranial meningiomas, and occurred at younger age, but showed similar surgical outcomes and recurrence risk to sporadic cases. #JNO Read more: https://t.co/3bxwhPrl2l
Tweet card summary image
link.springer.com
Journal of Neuro-Oncology - Meningiomas are the second most common type of tumor associated with Neurofibromatosis Type 2 Schwannomatosis (NF2-SWN). While the characteristics of intracranial...
0
1
7
@JNeurooncol
Journal of Neuro-Oncology
22 days
Sadagopan et al. showed that NOTCH3 promotes fatty acid oxidation and lipid depletion in aggressive meningiomas, driving ferroptosis resistance. CD36 upregulation and enhanced mitochondrial respiration supported this metabolic reprogramming.#JNO Read more: https://t.co/0NZq7U21BS
3
1
3
@JNeurooncol
Journal of Neuro-Oncology
22 days
Now available online! Issue No. 3 December 2025 #JNO
0
3
14
@JNeurooncol
Journal of Neuro-Oncology
23 days
Renovanz et al. conducted GLIOPT cluster-RCT in high-grade glioma. Physician-led psychosocial screening was not superior to questionnaires in facilitating referrals, but proved feasible and patient-centered for neurocognitively impaired cases.#JNO Link: https://t.co/YeQe8gKG2h
0
1
3
@JNeurooncol
Journal of Neuro-Oncology
26 days
Brand et al. reported long-term outcomes of modern RT for pituitary adenomas. LC reached 95% at 5 yrs and 75% at 20 yrs; proton therapy improved LC and OS vs photon RT. Hypopituitarism was main late toxicity, while visual deficits were rare.#JNO Read more: https://t.co/DQUhQMjiMF
0
0
6
@JNeurooncol
Journal of Neuro-Oncology
28 days
Kojundzic et al. analyzed breast cancer brain metastases by age. Women <40 were more likely to develop leptomeningeal disease and undergo CNS re-treatment, yet their progression-free and overall survival were comparable to older patients.#JNO Read more:
Tweet card summary image
link.springer.com
Journal of Neuro-Oncology - Breast cancer (BC) is the most frequent cancer among women and the second leading cause of central nervous system (CNS) metastases. While the epidemiology of CNS...
0
1
10
@JNeurooncol
Journal of Neuro-Oncology
30 days
Su et al. developed a diagnostic model using 9 CSF parameters, including cytology, to distinguish CNS infections from brain tumors. Phagocytes/monocytes were linked to tumors, while lymphocytes/plasma cells indicated infection (AUC~0.90).#JNO Read more:
Tweet card summary image
link.springer.com
Journal of Neuro-Oncology - Differentiating central nervous system infections (CNSIs) from brain tumors (BTs) is difficult due to overlapping features and the limited individual indicators, and...
0
1
3
@JNeurooncol
Journal of Neuro-Oncology
1 month
Sönksen et al. reported the first-year experience of the ERN PaedCan virtual tumor board for pediatric CNS tumors. Nineteen patients from 9 countries were discussed, with recommendations followed in nearly all cases and rated highly useful. #JNO Read more: https://t.co/Af43XP8Lwj
0
0
5
@duenas_gon28
ALFONSO DUEÑAS GONZALEZ
1 month
THE LAZARUS PHENOMENON doi: 10.3390/jcm12144704 Real-world experience outcome in patients with central nervous system metastases: information on 2,226 patients during a 15-year period. 2025.Neurooncol doi: 10.1007/s11060-025-05190-y @JNeurooncol @SMEOMX @IASLC @Spottingthespot
0
1
5
@JNeurooncol
Journal of Neuro-Oncology
1 month
Kann et al. analyzed 122 patients with lung cancer spinal metastases treated with SRS. LC rates were 88% at 6 months and 75% at 1 year, with pain relief in most patients and acceptable toxicity, including 8% vertebral fractures. #JNO Read more:
0
2
5